(Q45238820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

González GM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Wiedrhold NP

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lass-Flörl C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Warn P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Heep M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ghannoum MA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Guinea J

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

published in

Journal of Chemotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

272-281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567347%20AND%20SRC:MED&resulttype=core&format=json

Zygomycetes in human disease

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

A higher-level phylogenetic classification of the Fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Zygomycosis--current epidemiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Zygomycosis (mucormycosis): emerging clinical importance and new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Posaconazole as salvage therapy for zygomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

New and emerging treatments for fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.272